Deep brain stimulation-guided optogenetic rescue of parkinsonian symptoms - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Nature Communications Year : 2020

Deep brain stimulation-guided optogenetic rescue of parkinsonian symptoms


Deep brain stimulation (DBS) of the subthalamic nucleus is a symptomatic treatment of Parkinson's disease but benefits only to a minority of patients due to stringent eligibility criteria. To investigate new targets for less invasive therapies, we aimed at elucidating key mechanisms supporting deep brain stimulation efficiency. Here, using in vivo electrophysiology, optogenetics, behavioral tasks and mathematical modeling, we found that subthalamic stimulation normalizes pathological hyperactivity of motor cortex pyramidal cells, while concurrently activating somatostatin and inhibiting parvalbumin interneurons. In vivo opto-activation of cortical somatostatin interneurons alleviates motor symptoms in a parkinsonian mouse model. A computational model highlights that a decrease in pyramidal neuron activity induced by DBS or by a stimulation of cortical somatostatin interneurons can restore information processing capabilities. Overall, these results demonstrate that activation of cortical somatostatin interneurons may constitute a less invasive alternative than subthalamic stimulation.


Fichier principal
Vignette du fichier
s41467-020-16046-6.pdf (9.87 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

inserm-02625538 , version 1 (26-05-2020)



Sebastien Valverde, Marie Vandecasteele, Charlotte Piette, Willy Derousseaux, Giuseppe Gangarossa, et al.. Deep brain stimulation-guided optogenetic rescue of parkinsonian symptoms. Nature Communications, 2020, 11 (1), pp.2388. ⟨10.1038/s41467-020-16046-6⟩. ⟨inserm-02625538⟩
179 View
63 Download



Gmail Facebook X LinkedIn More